 |
|
|
| |
Switching to RPV/FTC/TAF From RPV/FTC/TDF or EFV/FTC/TDF: Week 96 Results
|
| |
| |
Reported by Jules Levin
CROI 2018 March 4-7 Boston MA
Anthony Mills,1 Cynthia Brinson,2 Claudia Martorell,3 Gordon Crofoot,4 Eric Daar,5 Olayemi Osiyemi,6 Bruce Rashbaum,7 David Shamblaw,8
Hans-Jürgen Stellbrink,9 Daniel Podzamczer,10 Hui Liu,11 Ya-Pei Liu,11 Danielle Porter,11 Sean E. Collins,11 Devi SenGupta11
1Mills Clinical Research, Los Angeles, CA; 2Central Texas Clinical Research, Austin, TX; 3Infectious Disease and the Research Institute, Springfield, MA; 4Gordon E. Crofoot MD, PA, Houston, TX; 5Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA;
6Triple O Research Institute P.A., West Palm Beach, FL; 7Capital Medical Associates, Washington, DC; 8La Playa Medical Group, San Diego, CA; 9ICH Study Center, Hamburg, Germany; 10Hospital Universitari de Bellvitge, Barcelona, Spain; 11Gilead Sciences, Inc., Foster City, CA
|
| |
|
|
|
|
|
